| Trends in major lower limb amputation related to peripheral arterial disease in Hungary: a nationwide study (2004–2012) E Kolossvary, T Ferenci, T Kovats, L Kovács, Z Jarai, G Menyhei, K Farkas European Journal of Vascular and Endovascular Surgery 50 (1), 78-85, 2015 | 45 | 2015 |
| Quantitative impact of direct, personal feedback on hand hygiene technique A Lehotsky, L Szilágyi, T Ferenci, L Kovács, R Pethes, G Wéber, ... Journal of Hospital Infection 91 (1), 81-84, 2015 | 25 | 2015 |
| Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study M Sulyok, M Makara, Z Rupnik, T Ferenci, E Újhelyi, L Kormos, Z Gerlei, ... European journal of gastroenterology & hepatology 27 (6), 679-685, 2015 | 23 | 2015 |
| The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes T Ferenci, A Körner, L Kovács Diabetes research and clinical practice 108 (1), 38-44, 2015 | 23 | 2015 |
| Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6 … A Kocsis, T Takács, C Jeney, Z Schaff, R Koiss, B Járay, G Sobel, K Pap, ... International journal of cancer 140 (5), 1119-1133, 2017 | 22 | 2017 |
| The issue of plasma asymmetric dimethylarginine reference range–A systematic review and meta-analysis B Németh, Z Ajtay, L Hejjel, T Ferenci, Z Ábrám, E Murányi, I Kiss PloS one 12 (5), e0177493, 2017 | 21 | 2017 |
| Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis–experiences from a single center K Farkas, M Rutka, T Ferenci, F Nagy, A Bálint, R Bor, Á Milassin, ... Expert Opinion on Biological Therapy 17 (11), 1325-1332, 2017 | 18 | 2017 |
| Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill T Ferenci, B Benyo, L Kovács, L Fisk, GM Shaw, JG Chase PloS one 8 (2), e57119, 2013 | 18 | 2013 |
| Can Google Trends data improve forecasting of Lyme disease incidence? M Kapitány‐Fövény, T Ferenci, Z Sulyok, J Kegele, H Richter, ... Zoonoses and public health 66 (1), 101-107, 2019 | 14 | 2019 |
| A koronavírus okozta COVID–19-pandémia. Korábbi tapasztalatok és tudományos evidenciák 2020. március végén A Váradi, T Ferenci, A Falus Orvosi Hetilap 161 (17), 644-651, 2020 | 12* | 2020 |
| Predicting body fat percentage from anthropometric and laboratory measurements using artificial neural networks T Ferenci, L Kovacs Applied Soft Computing 67, 834-839, 2018 | 11 | 2018 |
| Ramipril+ amlodipine and ramipril+ hydrochlorothiazide fixed-dose combinations in relation to patient adherence G Simonyi, T Ferenci, S Alföldi, C Farsang Journal of International Medical Research 44 (5), 1087-1091, 2016 | 11 | 2016 |
| Modeling and optimal control strategies of diseases with high public health impact L Kovács, P Szalay, T Ferenci, DA Drexler, J Sápi, I Harmati, Z Benyó 2011 15th IEEE International Conference on Intelligent Engineering Systems …, 2011 | 11 | 2011 |
| [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry] A Jánosi, P Ofner, Z Kiss, L Kiss, RG Kiss, J Dinnyés, Z Járai, G Nagy, ... Orvosi hetilap 158 (27), 1051, 2017 | 10* | 2017 |
| Persistence on treatment with the fixed combination of ramipril and amlodipine G Simonyi, T Ferenci Orvosi Hetilap 155 (47), 1882-1888, 2014 | 10* | 2014 |
| One year persistence of free and fixed dose combinations of perindopril/amlodipine G Simonyi, T Ferenci, M Medvegy, R Gasparics, E Finta Orvosi Hetilap 158 (36), 1421-1425, 2017 | 9* | 2017 |
| Early phase of the COVID-19 outbreak in Hungary and post-lockdown scenarios G Röst, FA Bartha, N Bogya, P Boldog, A Dénes, F Tamás, KJ Horváth, ... medRxiv, 2020 | 8 | 2020 |
| Comparing machine learning and regression models for mortality prediction based on the Hungarian Myocardial Infarction Registry P Piros, T Ferenci, R Fleiner, P Andréka, H Fujita, L Főző, L Kovács, ... Knowledge-Based Systems 179, 1-7, 2019 | 8 | 2019 |
| Modelling tumor growth under angiogenesis inhibition with mixed-effects models T Ferenci, J Sápi, L Kovács Acta Polytechnica Hungarica 14 (1), 221-234, 2017 | 8 | 2017 |
| Effective case/infection ratio of poliomyelitis in vaccinated populations G Bencskó, T Ferenci Epidemiology & Infection 144 (9), 1933-1942, 2016 | 8 | 2016 |
Levente KovácsProfessor, Obuda UniversityE-mail megerősítve itt: nik.uni-obuda.hu
